Skip to content

Effect of Camel Milk on Insulin and Incretin Response

The Effect of Camel Milk on Insulin and Incretin Response to a Mixed-meal Challenge in People With Normal Glucose Tolerance

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03725969
Enrollment
15
Registered
2018-10-31
Start date
2017-02-01
Completion date
2020-12-30
Last updated
2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity, Glucose Tolerance

Brief summary

To examine the differential effect of camel and cow milk on the physiological response, to a liquid mixed-meal challenge, in people with normal glucose tolerance

Detailed description

Camel milk is used as a traditional remedy throughout the Middle East and Indian Subcontinent for conditions such as type 2 diabetes and dyslipidemia. It is currently unclear how such an effect could be mediated in vivo and studies are limited. We performed this study as a pilot experiment to assess the effects of camel milk on Insulin, Glucose, GLP-1, C-peptide and Lipid profile.

Interventions

DIETARY_SUPPLEMENTCamel milk

Camel Milk administered 10 minutes before a mixed meal of carbohydrate and protein; 2-week washout between interventions

DIETARY_SUPPLEMENTCow milk

Cow milk administered 10 minutes before a mixed meal of carbohydrate and protein;2-week washout between interventions

Sponsors

Imperial College London Diabetes Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Masking description

Double-blind

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal glucose tolerance * BMI \< 30 kg/m2

Exclusion criteria

* Type 1 diabetes mellitus * Type 2 diabetes mellitus * Impaired fasting glucose or impaired glucose tolerance * Lactose intolerance * Weight loss / gain ≥ 5 kg in the preceding two months * Use of estrogenic drugs or corticosteroids * Known hypertriglyceridemia requiring treatment * History of heart attack, angina or cardiovascular disorder * History of malignant tumor * Pregnant or lactating women * Hemoglobin \< 12 for any reason * Recent surgery or major hemorrhage * History of bariatric or metabolic surgery

Design outcomes

Primary

MeasureTime frameDescription
Glucose response to camel and cow milk5 monthsThe difference between interventions in terms of peak of glucose
Response of glucose to camel and cow milk5 monthsThe difference between interventions in terms of area under the curve

Secondary

MeasureTime frameDescription
GLP-1 response to camel and cow milk5 monthsThe difference between interventions in terms of peak
Response of GLP-1 to camel and cow milk5 monthsThe difference between interventions in terms of area under the curve
Insulin response to camel and cow milk5 monthsThe difference between interventions in terms of peak
Response of C-peptide to camel and cow milk5 monthsThe difference between interventions in terms of area under the curve
C-peptide response to camel and cow milk5 monthsThe difference between interventions in terms of peak
Response of insulin to camel and cow milk5 monthsThe difference between interventions in terms of area under the curve

Countries

United Arab Emirates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026